IL-6-Th17/IL-17 activation is linked to osteoclastogenesis in chronic gouty arthritis

Introduction The mechanisms of chronic gouty arthritis (CGA) and its progressive bone destruction remain poorly understood. The purpose of this study was to explore the potential involvement of interleukin (IL)-6 and T helper 17 (Th17)/IL-17 responses in CGA-associated osteoclast formation. Methods Fifty-nine patients with gout and 28 healthy controls (HCs) were enrolled in this study. Transcriptome sequencing, Enzyme-Linked Immunosorbent Assay (ELISA) and flow cytometry were used to detect the levels of cytokines and Th17 cells’ response in CGA patients. Th17-enriched T-cell co-culture and IL-6/IL-17 neutralization experiments were used to assess the osteoclast formation in vitro . The effect of triptolide (TP) was evaluated in PBMC cultures, and the clinical changes following treatment with tripterygium glycoside (TG) were retrospectively examined in four CGA patients. Results CGA patients showed enrichment of IL-17 signaling, and the levels of CXCL1, CXCL2, IL-6 and IL-23 were cooperatively elevated. Also, the Th17-cell frequency, IL-17 production, and the capacity of naive T cells to differentiate into Th17 cells were also increased in CGA patients, which could be suppressed by anti-IL-6 antibody. Furthermore, CGA-derived Th17-enriched T cells increased osteoclast formation in co-culture, whereas IL-6 and IL-17 neutralization reduced osteoclast formation. And TP treatment in vitro showed lower IL-6 levels and reduced osteoclast formation in CGA. The four-patient treated with TG showed exploratory changes in inflammatory biomarkers and peripheral Th17 frequency after treatment. Discussion The findings support the potential involvement of IL-6/Th17/IL-17 responses in osteoclast formation in CGA, which links immune disorder to osteoclast activation, and provide a potential strategy for the use of Tripterygium-derived agents in CGA treatment.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-13
DOI
https://doi.org/10.3389/fimmu.2026.1996564
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

IL-6-Th17/IL-17 activation is linked to osteoclastogenesis in chronic gouty arthritis

Na Xu, Hong Di, Yun Zhang, Xuejun Zeng et al.
Frontiers in Immunology
Gout, Hyperuricemia, Uric Acid
article

IL-6-Th17/IL-17 activation is linked to osteoclastogenesis in chronic gouty arthritis

Na Xu, Hong Di, Yun Zhang, Xuejun Zeng, Bingqing Zhang
article en

Abstract

Introduction The mechanisms of chronic gouty arthritis (CGA) and its progressive bone destruction remain poorly understood. The purpose of this study was to explore the potential involvement of interleukin (IL)-6 and T helper 17 (Th17)/IL-17 responses in CGA-associated osteoclast formation. Methods Fifty-nine patients with gout and 28 healthy controls (HCs) were enrolled in this study. Transcriptome sequencing, Enzyme-Linked Immunosorbent Assay (ELISA) and flow cytometry were used to detect the levels of cytokines and Th17 cells’ response in CGA patients. Th17-enriched T-cell co-culture and IL-6/IL-17 neutralization experiments were used to assess the osteoclast formation in vitro . The effect of triptolide (TP) was evaluated in PBMC cultures, and the clinical changes following treatment with tripterygium glycoside (TG) were retrospectively examined in four CGA patients. Results CGA patients showed enrichment of IL-17 signaling, and the levels of CXCL1, CXCL2, IL-6 and IL-23 were cooperatively elevated. Also, the Th17-cell frequency, IL-17 production, and the capacity of naive T cells to differentiate into Th17 cells were also increased in CGA patients, which could be suppressed by anti-IL-6 antibody. Furthermore, CGA-derived Th17-enriched T cells increased osteoclast formation in co-culture, whereas IL-6 and IL-17 neutralization reduced osteoclast formation. And TP treatment in vitro showed lower IL-6 levels and reduced osteoclast formation in CGA. The four-patient treated with TG showed exploratory changes in inflammatory biomarkers and peripheral Th17 frequency after treatment. Discussion The findings support the potential involvement of IL-6/Th17/IL-17 responses in osteoclast formation in CGA, which links immune disorder to osteoclast activation, and provide a potential strategy for the use of Tripterygium-derived agents in CGA treatment.

Frontiers in ImmunologyVol. 17
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN)
National Natural Science Foundation of China
Good health and well-being
Gout, Hyperuricemia, Uric Acid
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon